Skip to main content

Table 3 Examples of genes predictive for response in the discovery but not validation datasets

From: Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Gene N = 210 Discovery
Pre-treatment
ANOVA t-test
N = 150 Validation
Pre-treatment
ANOVA t-test
CD28 0.026 0.158
CD80 0.012 0.368
FAIM3 0.008 0.638
FYN 0.006 0.962
IL18BP 0.020 0.958
IL32 0.021 0.686
IL7R 0.009 0.590
INPP4B 0.006 0.740